Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benoxaprofen, (+)-isomer
2. Benoxaprofen, (+-)-isomer
3. Benoxaprofen, (-)-isomer
4. Benoxaprofen, Ammonium Salt
5. Benoxaprofen, Monosodium Salt
6. Lrcl 3794
7. Oraflex
1. 51234-28-7
2. Uniprofen
3. Oraflex
4. Coxigon
5. Opren
6. Inflamid
7. Dl-benoxaprofen
8. Compound 90459
9. Benoxaprofene
10. Benoxaprofenum
11. Benoxaprofeno
12. 2-(2-(4-chlorophenyl)benzo[d]oxazol-5-yl)propanoic Acid
13. Lilly 90459
14. 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic Acid
15. (+-)-benoxaprofen
16. 2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
17. (1)-2-(4-chlorophenyl)benzoxazole-5-propionic Acid
18. Nsc 299582
19. Chebi:76114
20. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl-
21. Nsc-299582
22. 17szx404im
23. 2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
24. Compd 90459
25. Nsc299582
26. 2-(2-(4-chlorophenyl)-1,3-benzoxazol-5-yl)propanoic Acid
27. Benoxaprofene [inn-french]
28. Benoxaprofenum [inn-latin]
29. Benoxaprofeno [inn-spanish]
30. 2-(p-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
31. Benoxaprofen [usan:inn:ban]
32. Lrcl 3794
33. Oraflex (tn)
34. 67434-14-4
35. Einecs 257-069-7
36. Benoxaprofen (usan/inn)
37. Brn 1085080
38. Unii-17szx404im
39. (+-)-2-(p-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
40. (rs)-benoxaprofen
41. Einecs 266-692-3
42. (+/-)-benoxaprofen
43. Benoxaprofen [mi]
44. Benoxaprofen [inn]
45. Benoxaprofen [jan]
46. Benoxaprofen [usan]
47. Schembl24413
48. Benoxaprofen [mart.]
49. Compound-90459
50. Benoxaprofen [who-dd]
51. Chembl340978
52. Dtxsid4022650
53. (+-)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
54. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-alpha-methyl, (+-)-
55. Bdbm50088388
56. Db04812
57. Da-05331
58. Hy-13568
59. Cs-0007198
60. Ft-0662523
61. Ft-0662524
62. C90147
63. D03080
64. A905882
65. Q420082
66. 2-(4-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
67. 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic Acid #
68. (alphar)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
69. (alphas)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
70. (+/-)-2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
71. (.+/-.)-2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
72. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl, (.+/-.)-
73. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl, (+/-)-
| Molecular Weight | 301.72 g/mol |
|---|---|
| Molecular Formula | C16H12ClNO3 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 301.0505709 g/mol |
| Monoisotopic Mass | 301.0505709 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 384 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AE - Propionic acid derivatives
M01AE06 - Benoxaprofen
ABOUT THIS PAGE
45
PharmaCompass offers a list of Benoxaprofen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benoxaprofen manufacturer or Benoxaprofen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benoxaprofen manufacturer or Benoxaprofen supplier.
PharmaCompass also assists you with knowing the Benoxaprofen API Price utilized in the formulation of products. Benoxaprofen API Price is not always fixed or binding as the Benoxaprofen Price is obtained through a variety of data sources. The Benoxaprofen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benoxaprofen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benoxaprofen, including repackagers and relabelers. The FDA regulates Benoxaprofen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benoxaprofen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benoxaprofen supplier is an individual or a company that provides Benoxaprofen active pharmaceutical ingredient (API) or Benoxaprofen finished formulations upon request. The Benoxaprofen suppliers may include Benoxaprofen API manufacturers, exporters, distributors and traders.
click here to find a list of Benoxaprofen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benoxaprofen DMF (Drug Master File) is a document detailing the whole manufacturing process of Benoxaprofen active pharmaceutical ingredient (API) in detail. Different forms of Benoxaprofen DMFs exist exist since differing nations have different regulations, such as Benoxaprofen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benoxaprofen DMF submitted to regulatory agencies in the US is known as a USDMF. Benoxaprofen USDMF includes data on Benoxaprofen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benoxaprofen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benoxaprofen suppliers with USDMF on PharmaCompass.
Benoxaprofen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benoxaprofen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benoxaprofen GMP manufacturer or Benoxaprofen GMP API supplier for your needs.
A Benoxaprofen CoA (Certificate of Analysis) is a formal document that attests to Benoxaprofen's compliance with Benoxaprofen specifications and serves as a tool for batch-level quality control.
Benoxaprofen CoA mostly includes findings from lab analyses of a specific batch. For each Benoxaprofen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benoxaprofen may be tested according to a variety of international standards, such as European Pharmacopoeia (Benoxaprofen EP), Benoxaprofen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benoxaprofen USP).
